Health Care/Hospital News & Press Release Distribution

Interim report, May-October 2020/21

STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- In Elekta's second quarter, we managed to perform better than the overall radiotherapy market both in terms of orders and revenue despite continuous challenging circumstances. We also improved margins and stabilized cash flow. The launch of our new Harmony...

2020-11-26 15:01 6681

Gustaf Salford appointed Elekta CEO by Board of Directors

STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Gustaf Salford has been appointed to the role of President and CEO, effective immediately. He has been Acting CEO since earlyJune 2020. Elekta's Board of Directors carried out an extensive search process, with the c...

2020-11-26 14:59 5868

Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome

SHANGHAI and HONG KONG, Nov. 26, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", HKSE stock code: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-inclass therapeutics in hematolog...

2020-11-26 14:04 5835

Senhwa Announces Multiple IND Application Submissions to US FDA and Health Canada for the Treatment of Solid Tumors with BRCA2 or PALB2 Mutations

TAIPEI and SAN DIEGO, Nov. 25, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that it has submitted multiple Investigational New D...

2020-11-26 10:34 1952

Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome

SHANGHAI and HONG KONG, Nov. 26, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", HKSE stock code: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-inclass therapeutics in hematolog...

2020-11-26 10:32 5296

Frost & Sullivan Examines 8 Strategic Imperatives for Growth in a Post-COVID World

Experts to discuss top strategic imperatives to move your organization toward its desired vision and culture in upcoming webinar SANTA CLARA, Calif., Nov. 26, 2020 /PRNewswire/ -- While visualizing and articulating a company's possible future has always been vital to long-term success, the disru...

2020-11-26 01:23 1964

Frost & Sullivan Examines 8 Strategic Imperatives for Growth in a Post-COVID World

Sirtex Medical and China Grand Pharmaceutical announce SIR-Spheres® Y-90 resin microspheres milestone

SIR-Spheres® new drug application is accepted by the National Medical Products Administration of China WOBURN, Mass., Nov. 26, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that Sirtex with the support of its shareh...

2020-11-26 01:17 1925

RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA

LUND, Sweden, Nov. 25, 2020 /PRNewswire/ -- RhoVac, a clinical stage company today announced that the American FDA has granted Fast Track Designation to the company's drug candidate, RV001. Fast Track Designation is granted to investigational drugs for expedited review by the FDA, to facilitate ...

2020-11-25 16:06 1514

Indonesia's Government to Help Improve the Welfare of Non-Civil Servant Educators and Educational Personnel Through Wage Subsidies

* Channeling a total of Rp 3.6 trillion in aid to two million people. * Beneficiaries include lecturers at state and private universities, teachers, as well as library, laboratory and administrative staff who all receive a lump sum ofRp 1.8 million each. JAKARTA, Indonesia, Nov. 25, 2020 /PRN...

2020-11-25 13:11 1910

Indonesia's Government to Help Improve the Welfare of Non-Civil Servant Educators and Educational Personnel Through Wage Subsidies

Ascentage Pharma Announces First Patient Dosed in Europe in the Phase Ib/II Study of the Bcl-2 inhibitor APG-2575 in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

SUZHOU, China and ROCKVILLE, Md., Nov. 25, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a Phase Ib/II clinical ...

2020-11-25 08:27 2326

MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients

NYON, Switzerland, Nov. 25, 2020 /PRNewswire/ -- MedAlliance has announced completion of patient enrolment in theISABELLA Clinical Trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodialysis. SE...

2020-11-25 08:00 2523

MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients

Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Awardees of the Seoul Innovation QuickFire Challenge on Healthcare for the New Normal in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute

- Awardees DC Medical and deepmedi recognized for pioneering efforts leveraging data and health technologies to advance potentially life-saving ideas aimed at improving patient care during the COVID-19 pandemic and beyond. SEOUL, South Korea, Nov. 25, 2020 /PRNewswire/ -- Janssen Korea Ltd. and ...

2020-11-25 07:00 2805

RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences

TEL AVIV, Israel and RALEIGH, N.C., Nov. 25, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will present and participate at the following virtual conferen...

2020-11-25 07:00 2784

Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

BARCELONA, Spain, Nov. 25, 2020 /PRNewswire/ -- AlmirallShare , the open innovation platform of Almirall, S.A. (ALM), announces two new collaborations with theUniversity of South Australia and the Fundació Institut de Recerca de ...

2020-11-25 06:00 5699

China Biologic Reports Financial Results for the Third Quarter of 2020

BEIJING, Nov. 24, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the third quarter of 2020. Third Quarter...

2020-11-25 05:30 12103

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021

HONG KONG, Nov. 25, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2020-11-25 05:16 12978

The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets

RDIF continues expanding existing agreements with international manufacturing partners to produce the vaccine for more than 500 million people in 2021 MOSCOW, Nov. 25, 2020 * The cost of one dose of the Sputnik V vaccine for international markets will be less than$10. Sputnik V is a two dose ...

2020-11-25 04:38 1397

PwC Actuarial Services Hails Aon's PathWise® Platform for IFRS 17 Reporting

LONDON, Nov. 24, 2020 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, today announces that professional services firm PwC has completed a successful review of Aon's PathWise® platform for re/insurer...

2020-11-24 23:00 12004

NaviFUS highlights clinical trial data and device capabilities at virtual International Focused Ultrasound Symposium

TAIPEI, Nov. 24, 2020 /PRNewswire/ -- The 7th International Focused Ultrasound Symposium organized by the U.S. Focused Ultrasound Foundation took place from 11/9 to 11/13 in virtual format this year due to theCOVID-19 epidemic. During the 5-day conference, participants presented and exchanged inf...

2020-11-24 22:26 1292

Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose

MOSCOW, Nov. 24, 2020 /PRNewswire/ -- * The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis of data obtained 28 days after administering the first dose (7 days after the second dose). * Calculation was based on the analysis of data on volunteers (n = 18,794) ...

2020-11-24 22:14 1442